Pershing Square Sohn Cancer Research Alliance


The Pershing Square Sohn Cancer Research Alliance is dedicated to playing a catalytic role in accelerating cures for cancer by enabling the pursuit of the most innovative and advanced cancer research and by facilitating collaborations between science and business.

Early-Stage Funding for Cancer Research

The Prize for young investigators provides early-stage funding opportunities to New York scientists with innovative ideas in cancer research. The program surrounding the Prize is a catalyst in bridging the gap between the academic scientific community and the business community.

LEARN MORE2020 PRIZE WINNERS

2020 Prize Winners

News

August 14, 2020
TINY PROTEIN PACKAGES RELEASED FROM CELLS MAY SERVE AS BIOMARKERS FOR EARLY BLOOD-BASED CANCER DIAGNOSIS

WEILL CORNELL MEDICINE — Tiny packets called extracellular vesicles and particles (EVPs), released by cancer and immune cells, contain specific proteins that may serve as reliable biomarkers for diagnosing early-stage cancer, according to investigators at Weill Cornell Medicine and Memorial Sloan Kettering.

A new study published August 13 in Cell identifies new biomarkers in EVPs that can be used to help discriminate these particles from others isolated from tissue and blood samples, so they can be used for analysis in diagnostic panels for detection of early malignancy. EVPs associated with cancer could also offer scientists valuable targets for drug development.

“One test tube of blood contains billions of EVPs,” said co-senior author Dr. David C. Lyden, Stavros S. Niarchos Professor in Pediatric Cardiology, and professor of pediatrics and of cell and developmental biology at Weill Cornell Medicine [and PSSCRA Scientific Review Council Member]. “This means a person with cancer has an abundant source of cancer-associated EVPs that clinicians could assess for diagnosis.”

READ MORE

Events

October 24, 2019 
2019 PRIX GALIEN PRESIDENT’S DINNER, ANNUAL GALIEN FORUM, AND ANNUAL PRIX GALIEN USA AWARDS CEREMONY

The Prix Galien recognizes outstanding innovation to improve the human condition by means of biomedical research.  It is considered the industry’s equivalent of the Nobel Prize, the highest accolade for biomedical research and development.  The annual Galien Forum is a meeting-of-the minds at which pressing issues are debated by front-runners in industry, academia and government. This is a special opportunity for recipients of the Pershing Square Sohn Prize for Young Investigators in Cancer Research to spend time with such leaders.

Pershing Square Sohn Prize winners, Scientific Review Council members, and guests which included individuals from philanthropy, academia, industry, and business attended this year’s Forum at the Alexandria Center for Life Science in New York City. The event featured talks by executives from the pharmaceutical, biotechnology, and medical industries, as well as top academics and government representatives.  Following the Forum, select guests were invited to attend the Prix Galien Awards Ceremony at the American Museum of Natural History.

READ MORE

“The Pershing Square Foundation is proud to support scientific leaders in the fight against cancer.”

Bill Ackman, Co-Founder. The Pershing Square Foundation